#United States #New York #Rosen Law Firm #securities lawsuit #Park Ha

Investors Consider Leading a Class Action Against Park Ha Biological Technology

In recent developments, the Rosen Law Firm, a globally recognized firm specializing in investor rights, has initiated a class action lawsuit against Park Ha Biological Technology Co., Ltd. (NASDAQ PHH, BYAH). The lawsuit targets all purchasers of securities associated with Park Ha between December 27, 2024, and July 8, 2025. This legal move highlights significant allegations regarding misleading information presented by the company's executives that may have impacted stock trading and investor confidence.

Understanding the Class Action Dynamics

For those unfamiliar with class action lawsuits, they allow a group of investors harmed by the same alleged misconduct to pursue legal action collectively. In this instance, if you purchased shares during the specified Class Period, you may be eligible to join this class action and potentially receive compensation. It’s important to note that participation in a class action doesn't require upfront legal fees, as the Rosen Law Firm applies a contingency fee arrangement, meaning they only collect fees if you win.

The Need for Lead Plaintiffs

The firm is encouraging interested investors to act swiftly, as a lead plaintiff must file in court by the deadline of September 28, 2026. A lead plaintiff plays a crucial role in representing the interests of all class members and guiding the litigation process. If you believe you are eligible, you can learn more about how to join the lawsuit via their website or by contacting the firm directly.

Why Choose Rosen Law Firm?

The Rosen Law Firm has a strong track record of success in leading securities class action cases. They have achieved notable verdicts, including the largest securities class action settlement against a Chinese company. The firm was ranked first in 2017 by ISS Securities Class Action Services for the number of settlements and has consistently ranked among the top firms in the field since 2013, recovering billions for investors. Their success is rooted in extensive experience and a commitment to protecting the rights of retail investors.

Core Allegations Against Park Ha

The lawsuit outlines that, throughout the Class Period, the defendants allegedly made materially false and misleading statements regarding the company’s operations and trading activities. Key points of concern include:
1. Involvement in Fraudulent Activities: The company is accused of participating in a fraudulent stock promotion scheme utilizing misinformation spread through social media and impersonation of financial professionals.
2. Omission of Critical Information: Park Ha’s public disclosures failed to mention these negative developments and risks, which created an illusion of financial health and stability.
3. Manipulative Trading Practices: The structure of Park Ha’s Initial Public Offering (IPO) was reportedly designed with an unusually low public float. This setup allegedly facilitated manipulative trading activities that artificially inflated stock prices.
4. Misleading Investor Communications: Positive statements made by the defendants about Park Ha’s prospects and operational health are said to lack a reasonable basis, further misleading investors.

Next Steps for Investors

If you've invested in Park Ha during the mentioned Class Period, it’s in your best interest to consider joining the class action. To do so, you can visit the Rosen Law Firm’s website at Rosen Legal or contact Phillip Kim, Esq. via the toll-free number provided. The firm will guide you through the necessary steps involved in joining the class action.

Conclusion

In summary, the ongoing situation with Park Ha Biological Technology serves as a critical reminder of the myriad risks associated with investing in securities. Investors can benefit from being informed and proactive. Joining a class action lawsuit not only provides a path to potential financial restitution but also contributes to holding companies accountable for their actions. Stay connected with the Rosen Law Firm for updates on this case and other related developments.